Draegerwerk Ag & Co. Kgaa · XETR:DRW8

Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — H1 2020 Earnings Presentation

13 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Aug 13, 2020

  1. Slide 1: H1 Conference Call

    H1 Conference Call Drägerwerk AG & Co. KGaA Lübeck, August 13, 2020

  2. Slide 2: Disclaimer

    Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d

  3. Slide 3: Business Highlights H1

    Business Highlights H1  Corona pandemic boosts order entry for intensive care medical products as well as light breathing protection in safety. “Non-Covid” product areas with lower demand.  High order entry of Q1 starting to translate into net sales in Q2. Improving margins.  Production ramp-up t

  4. Slide 4: Order Development in H1

    Order Development in H1 Order entry (€ million) Group Americas Europe AAA Net Sales + 27.4% + 37.2% + 7.2% Safety 658 +29% +6.6% +106% + 59.8% + 148.6% + 66.9% +23.5% Medical 1,634 Group 2,291 +76% + 48.6% +99.2% + 48.0% +17.1% Growth rates are net of currency effects 4

  5. Slide 5: Business development Group

    Business development Group Net Sales Order entry 6M 2019 6M 2020 fx-adj. +26.5% +17.1% Europa 711.3 1,410.9 99.2 Currency Currency Americas 262.2 377.6 48.6 adjusted adjusted +24.3% +15.6% AAA 346.8 502.9 48.0 nominal nominal Group 1,320.4 2,291.4 75.7 634 788 1,236 1,428  Strong order entry in H1

  6. Slide 6: Business development Medical

    Business development Medical Net Sales Order entry 6M 2019 6M 2020 fx-adj. +38.1% +23.5% Europa 395.8 980.7 >+100 Currency Currency adjusted adjusted Americas 171.4 263.8 59.8 +35.5% +21.9% AAA 237.2 389.4 66.9 nominal nominal Medical 804.4 1,633.9 >+100 394 533 762 929  COVID-19 drives exceptional

  7. Slide 7: Business development Safety

    Business development Safety Net Sales Order entry 6M 2019 6M 2020 fx-adj. +7.6% +6.6% Currency Currency Europa 315.5 430.3 37.2 adjusted adjusted Americas 90.8 113.8 27.4 +6,0% +5.4% nominal nominal AAA 109.6 113.5 7.2 Safety 515.9 657.5 29.1 241 255 474 499  The demand for light breathing protecti

  8. Slide 8: Key figures

    Key figures 6M 2019 6M 2020 Change € million € million % Cashflow (from operating activities) 31.3 33.9 8.2 Investments 60.6 60.9 0.5 1 Cash and cash equivalents 196.3 208.7 6.3 Net financial debt1 171.2 494.1 >+100 Net financial debt 1 /EBITDA 2 0.90 1.60 Capital employed 1 1,448.5 1,466.0 1.2 ROCE

  9. Slide 9: Outlook 2020

    Outlook 2020 EXPECTATIONS FOR FISCAL YEAR 2020 2019 2020e 5.9% 14.0 - 22.0 % Net sales (net of currency effects) (net of currency effects) EBIT margin 2.4% 7.0 - 11.0 % 1 Dräger Value Added EUR -32.7 million EUR 110 - 260 Mio. 1 Based on exchange rates at the start of fiscal year 2020 9

  10. Slide 10: Questions & Answers

    Questions & Answers Drägerwerk AG & Co. KGaA

  11. Slide 11: Financial calendar

    Financial calendar Dräger publishes preliminary results approximately 2 weeks before the dates of the quarterly reports. Preliminary results for the full year are published in January. - March 5, 2020 Final 2019 figures Conference call - April 30, 2020 Report for the first three months 2020 Conferen

  12. Slide 12: Contact

    Contact Melanie Kamann Thomas Fischler Corporate Communications Investor Relations Drägerwerk AG & Co. KGaA Drägerwerk AG & Co. KGaA Moislinger Allee 53−55 Moislinger Allee 53−55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel +49 451 882-3998 Tel +49 451 882-2685 Fax +49 451 882-3944 Fax +49 451 88

  13. Slide 13: Thank you

    Thank you Drägerwerk AG & Co. KGaA 13

Drägerwerk AG & Co. KGaA — H1 2020 Earnings Presentation on 6ix